Cantel Medical Corp. reported net income of $16,997, or $0.41 per diluted share, on a 14.8% increase in net sales to $205,502 for the fourth quarter ended July 31, 2017. This compares with net income of $16,291, or $0.39 per diluted share, on net sales of $179,002 for the fourth quarter ended July 31, 2016.
Cantel Medical announced today that it has completed its previously announced acquisition of BHT Hygienetechnik Holding GmbH (“BHT Group”), the German market leader in automated endoscope reprocessing and related equipment and services as well as flexible endoscope repair.
Cantel Medical announced today that it entered into a definitive agreement to purchase BHT Hygienetechnik Holding GmbH (“BHT Group”), the German market leader in automated endoscope reprocessing and related equipment and services and flexible endoscope repair.
Company celebrates 20th year of leadership in infection prevention.
Cantel Medical is a global company dedicated to delivering innovative infection prevention products and services for patients, caregivers, and other healthcare providers, which improve outcomes and help save lives. Through an expansive portfolio of endoscopy, water purification and filtration, and healthcare disposables, Cantel Medical provides high-quality infection prevention solutions and unsurpassed service, touching millions of patients each year around the world.